Buy tricor no prescription
Tablets-film-coated white, with the inscription on one side and company logo – on the other.
1 tab. – tricor side effects (micronized) – 145 mg.
Excipients: sucrose, sodium l tricor side effects l sulfate, lactose monohydrate, crospovidone, microcrystalline cellulose, colloidal silicon dioxide, hypromellose, sodium tricor side effects, magnesium stearate.
The composition of the envelope: tricor side effects OY-B-28920 (polyvinyl alcohol, titanium dioxide, talc, soy lecithin, tricor side effects gum).
Clinico-pharmacological group: lipid-lowering drug.
Pharmacological action
Lipid-lowering means a group derived fibroevoy acid. Fenofibrate has the ability to modify the content of lipids in the human organism due to activation of receptor PPAR-α (alpha receptors are activated does tricor cause weight gain). Fenofibrate increases lipolysis and elimination from the plasma of atherogenic lipoproteins with a high content of triglycerides through the activation of receptor PPAR-α, lipoprotein lipase and reducing the synthesis apoproteina C-III.
The above effects lead to a decrease in the content fraction of LDL and VLDL, which include apoprotein B (apo B), and increase in the content of HDL fraction, which include apo A-I and apo A-II. In addition, due to the correction of violations of synthesis and catabolism of VLDL, does tricor cause weight gain increases LDL clearance and reduces the content of small and dense LDL particles (increase of LDL observed in patients with atherogenic lipid phenotype is accompanied by a high risk of CHD). In clinical studies, it was noted that the use of fenofibrate reduces total cholesterol by 20-25% and triglycerides by 40-55% at raising HDL-C by 10-30%. In patients with hypercholesterolemia, in which LDL-cholesterol levels decreased by 20-35% the use of fenofibrate led to a decline in the ratio: total Xc / HDL-C, Hs-LPNP/Hs-LPVP and apo B / apo A-I, is a marker for atherogenic risk. Considering the effect of does tricor cause weight gain on LDL-cholesterol and triglycerides, the use of the drug effective in patients with hypercholesterolemia, whether unaccompanied or accompanied by tricor settlement , including secondary hyperlipoproteinemia, such as diabetes mellitus does tricor cause weight gain. During treatment with fenofibrate can significantly decrease or even disappear entirely extravascular deposits Xc (tendinous and tuberous xanthoma). Patients with elevated levels of fibrinogen who received does tricor cause weight gain treatment, a marked decrease in this indicator, as well as in patients with elevated levels of lipoproteins.
In the treatment of fenofibrate decrease the concentration of C-reactive protein and other markers of inflammation. For patients with tricor lawsuit and hyperuricaemia additional advantage is that fenofibrate has urikozurichesky effect, which leads to a decrease in the concentration of uric acid by approximately 25%. In the clinical study and in experiments on animals have shown that tricor lawsuit reduces platelet aggregation caused by adenosine diphosphate, tricor lawsuit acid and epinephrine.
Pharmacokinetics
Suction
After ingestion tricor lawsuit 145 mg Cmax achieved within 2-4 h. Cmax in blood plasma and the total effect of micronized fenofibrate in the form of nanoparticles (Traykor 145 mg) does not depend on the simultaneous food intake (and therefore the drug can be taken at any time, regardless of the meal ).
Distribution
Tricor 145mg acid strongly and more than 99% bound to plasma albumin.
Metabolism
After oral administration, fenofibrate is rapidly hydrolyzed esterases. The plasma is found only major active metabolite of fenofibrate – tricor 145mg acid.
Prolonged use tricor 145mg acid concentration in plasma remains stable, regardless of the individual patient. Fenofibrate is not a substrate for CYP3A4, is not involved in the microsomal metabolism.
Withdrawal
We derive mainly from the urine in the form tricor 145mg acid and glucuronide conjugate. Within 6 days fenofibrate appears almost completely. Pharmacokinetics in special clinical cases of elderly patients total body clearance lipator and tricor interactions acid does not change.
*
tricor settlement
and hypertriglyceridemia isolated or mixed (dyslipidemia type IIa, IIb, IV) with the ineffectiveness of non-medicinal therapies (lipid-lowering diet, weight loss, increased physical activity), especially when associated with dyslipidemia risk factors such as hypertension and smoking;
*
secondary hyperlipoproteinemia, in cases where hyperlipoproteinemia persists despite effective treatment of underlying disease (eg, dyslipidemia in diabetes mellitus).
Dosage regimen
Adults appoint 1 tab. 1 times / day.
Tricor 145mg can go to receive 1 tab. Traykora 145 mg dose without additional correction.
Patients taking one tab. fenofibrate 160 mg / day, can go to receive 1 tab. Llipator and tricor interactions mg dose without additional adjustments.
Elderly patients are encouraged to nominate a standard dose for adults.
Use of the drug in patients with liver disease is not known.
Drug Traykor 145 mg taken at any time of day, regardless of the meal, a tablet should be swallowed whole, without chewing, with a glass of water.
The drug should take a long time, while continuing to diet, which the patient adhered to before treatment lipator and tricor interactions.